CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

COL Q05546-1 GLY 000221 (Collection)

Taxon:

Rattus norvegicus

Taxonomy (Entity type)
Protein:

TENR RAT

Protein (Entity type)
Project:

Portal

Project (Entity type)
Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)
Dcc:

GlyGen

DCC (Entity type)
Collection:

rat proteoform glycosylation sites unicarbkb.csv

File (Entity type)
Description:Information for protein Q05546-1 in the context of file GLY_000221
Creation Time:2026-03-02 20:00:41.000000
Results found

Linked to

 

Label

Description

 

File

rat proteoform glycosylation sites unicarbkb.csv

File (Entity type)

A 735 KB file from GlyGen as part of the Portal project

Compound

G25987BV

Compound (Entity type)

type="BaseComposition" mass="1462.54443449" permass="1812.93568624" monosaccharides="8" is_motif="Fa...

Compound

G50073PQ

Compound (Entity type)

type="BaseComposition" mass="1770.65516686" permass="2191.12466896" monosaccharides="10" is_motif="F...

Compound

G48975GN

Compound (Entity type)

type="Saccharide" mass="1770.65516686" permass="2191.12466896" monosaccharides="10" is_motif="False"...

Compound

G97459BD

Compound (Entity type)

type="Saccharide" mass="1770.65516686" permass="2191.12466896" monosaccharides="10" is_motif="False"...

Protein

TENR RAT

Protein (Entity type)

Tenascin-R (precursor)

Post Translational Modification

q05546-1 580asn 580asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q05546-1 1259asn 1259asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

  • File

    rat proteoform glycosylation sites unicarbkb.csv

    File (Entity type)

    A 735 KB file from GlyGen as part of the Portal project

  • Compound

    G25987BV

    Compound (Entity type)

    type="BaseComposition" mass="1462.54443449" permass="1812.93568624" monosaccharides="8" is_motif="Fa...

  • Compound

    G50073PQ

    Compound (Entity type)

    type="BaseComposition" mass="1770.65516686" permass="2191.12466896" monosaccharides="10" is_motif="F...

  • Compound

    G48975GN

    Compound (Entity type)

    type="Saccharide" mass="1770.65516686" permass="2191.12466896" monosaccharides="10" is_motif="False"...

  • Compound

    G97459BD

    Compound (Entity type)

    type="Saccharide" mass="1770.65516686" permass="2191.12466896" monosaccharides="10" is_motif="False"...

  • Protein

    TENR RAT

    Protein (Entity type)

    Tenascin-R (precursor)

  • Post Translational Modification

    q05546-1 580asn 580asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    q05546-1 1259asn 1259asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.